Artykuły w czasopismach na temat „Anti diabetic drugs”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Anti diabetic drugs”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Ulfa, Ridha, Syarifah NYRS Assegaf, and Mistika Zakia. "PEDULI PENYAKIT TIDAK MENULAR DENGAN SKRINING KESEHATAN, BEDAH BUKU DAN PENYULUHAN PENGGUNAAN OBAT ANTI DIABETIK, OBAT HIPERURISEMIA DAN OBAT DISLIPIDEMIA YANG RASIONAL." Medical Dedication (medic) : Jurnal Pengabdian kepada Masyarakat FKIK UNJA 5, no. 1 (2022): 396–402. http://dx.doi.org/10.22437/medicaldedication.v5i1.18681.
Pełny tekst źródłaNanda, Oryza Dwi, Bambang Wiryanto, and Erwin Astha Triyono. "Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus." Amerta Nutrition 2, no. 4 (2018): 340. http://dx.doi.org/10.20473/amnt.v2i4.2018.340-348.
Pełny tekst źródłaWalia, Smily, J. S. Dua, and D. N. Prasad. "Herbal Drugs with Anti-Diabetic Potential." Journal of Drug Delivery and Therapeutics 11, no. 6 (2021): 248–56. http://dx.doi.org/10.22270/jddt.v11i6.5051.
Pełny tekst źródłaSasikumar, Amithkumar, and Sheetal S. "Bruns–Garland syndrome precipitated by anti-tuberculous therapy in a patient with type 2 diabetes mellitus." Nepal Journal of Neuroscience 19, no. 1 (2022): 66–67. http://dx.doi.org/10.3126/njn.v19i1.40952.
Pełny tekst źródłaShaha, Kartick Chanda, Sharmin Jahan, Md Ziaur Rahman Mamun, Md Shafiqur Rahman, Farjana Ahmed, and Bhagyashree Karmokar Jyoti. "Prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at a private Medical College Hospital in Mymensingh." Journal of Dhaka National Medical College & Hospital 23, no. 1 (2017): 29–32. https://doi.org/10.3329/jdnmch.v23i1.78063.
Pełny tekst źródłaSiddhi, Nigade* Dinesh Ingole Arundhati Kore Jagruti Shelar. "Review On Anti-Diabetic Drug and Treatment." International Journal of Pharmaceutical Sciences 3, no. 6 (2025): 185–95. https://doi.org/10.5281/zenodo.15574490.
Pełny tekst źródłaSingh, Ved Prakash. "An Overview on Anti Diabetic Drugs and Development." Science & Technology Journal 4, no. 2 (2016): 113–23. http://dx.doi.org/10.22232/stj.2016.04.02.05.
Pełny tekst źródłaDevkota, HP, A. Adhikari-Devkota, S. Yahara, and P. Basnet. "Anti-oxidative Activity of Nepalese Traditional Anti-diabetic Medicines." Nepal Journal of Science and Technology 14, no. 2 (2014): 151–54. http://dx.doi.org/10.3126/njst.v14i2.10429.
Pełny tekst źródłaKapur, Ajita, Harmeet Singh Rehan, Lalit Kumar Gupta, and Madhur Yadav. "Pattern of anti-diabetic drugs prescribed for type 2 diabetes mellitus patients in a tertiary care hospital of India: an observational study." International Journal of Basic & Clinical Pharmacology 8, no. 7 (2019): 1657. http://dx.doi.org/10.18203/2319-2003.ijbcp20192667.
Pełny tekst źródłaGalstyan, Gagik R., Ekaterina A. Shestakova, and Igor A. Sklyanik. "Obesity and type 2 diabetes: can we find a compromised treatment solution?" Diabetes mellitus 20, no. 4 (2017): 270–78. http://dx.doi.org/10.14341/dm8726.
Pełny tekst źródłaChekhonin, E. S., and O. A. Pavlovskiy. "ANTI-VEGF THERAPY FOR DIABETIC RETINOPATHY." Bulletin of Pirogov National Medical & Surgical Center 19, no. 4 (2024): 119–23. http://dx.doi.org/10.25881/20728255_2024_19_4_s1_119.
Pełny tekst źródłaAgyemang, Kojo, Lifeng Han, Erwei Liu, Yi Zhang, Tao Wang, and Xiumei Gao. "Recent Advances inAstragalus membranaceusAnti-Diabetic Research: Pharmacological Effects of Its Phytochemical Constituents." Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–9. http://dx.doi.org/10.1155/2013/654643.
Pełny tekst źródłaCHEN, SHYI-MING, YUN-HOU HUANG, and RUNG-CHING CHEN. "A RECOMMENDATION SYSTEM FOR ANTI-DIABETIC DRUGS SELECTION BASED ON FUZZY REASONING AND ONTOLOGY TECHNIQUES." International Journal of Pattern Recognition and Artificial Intelligence 27, no. 04 (2013): 1359001. http://dx.doi.org/10.1142/s0218001413590015.
Pełny tekst źródłaAndi Hutami Endang. "Expert System of Anti-Diabetic Medicine Selection." Journal of Computer Science and Informatics Engineering (J-Cosine) 5, no. 2 (2021): 175–82. http://dx.doi.org/10.29303/jcosine.v5i2.425.
Pełny tekst źródłaMehani, Rekha, and Parag Sharma. "Cost variation analysis of oral anti-diabetic drugs." International Journal of Basic & Clinical Pharmacology 7, no. 9 (2018): 1709. http://dx.doi.org/10.18203/2319-2003.ijbcp20183476.
Pełny tekst źródłaHadid, Khalil A., Fawaz A. Alassaf, and Mohammed N. Abed. "Beyond blood sugar: exploring the anti-inflammatory frontier of antidiabetic medications to alleviate diabetic complications." Romanian Journal of Medical Practice 19, no. 1 (2024): 76–83. http://dx.doi.org/10.37897/rjmp.2024.1.11.
Pełny tekst źródłaP., Anil Kumar, and Raj Kumar K. "Prescribing pattern of antidiabetic drugs in tertiary care hospital." International Journal of Basic & Clinical Pharmacology 10, no. 3 (2021): 251. http://dx.doi.org/10.18203/2319-2003.ijbcp20210555.
Pełny tekst źródłaKim, Se-Eun, and Byung-Su Yoo. "Anti-Diabetic Drugs in Cardiovascular Disease." Korean Journal of Medicine 96, no. 2 (2021): 85–91. http://dx.doi.org/10.3904/kjm.2021.96.2.85.
Pełny tekst źródłaSwetha E. Jeganathan, V. "Anti-Angiogenesis Drugs in Diabetic Retinopathy." Current Pharmaceutical Biotechnology 12, no. 3 (2011): 369–72. http://dx.doi.org/10.2174/138920111794480525.
Pełny tekst źródłaKumar, R., D. M. Kerins, and T. Walther. "Cardiovascular safety of anti-diabetic drugs." European Heart Journal - Cardiovascular Pharmacotherapy 2, no. 1 (2015): 32–43. http://dx.doi.org/10.1093/ehjcvp/pvv035.
Pełny tekst źródłaAbouzekry, Sara S., Marwa T. Badawy, Nada M. Ezzelarab, and Ahmed Abdellatif. "Phytotherapy for diabetes mellitus; A review of Middle Eastern and North African folk medicinal plants." Journal of Herbmed Pharmacology 10, no. 1 (2020): 1–13. http://dx.doi.org/10.34172/jhp.2021.01.
Pełny tekst źródłaKaur, Pardeep, Munish Kumar, Jyoti Parkash, and D. N. Prasad. "Oral hypoglycemic drugs: An overview." Journal of Drug Delivery and Therapeutics 9, no. 3-s (2019): 770–77. http://dx.doi.org/10.22270/jddt.v9i3-s.2815.
Pełny tekst źródłaDalvi, K. V., and Meenal D. Lad. "EXPERIMENTAL STUDY OF ATIBALA (ABUTILON INDICUM LINN SWEET) ROOT WITH EQUAL QUANTITY OF SUGAR (SITA) AND COW MILK (GODUGDDHA) IN RELATION TO ANTI-DIABETIC ACTIVITY IN STREPTOZOTOCIN INDUCED ALBINO WISTAR RATS." International Journal of Advanced Research 11, no. 11 (2023): 150–57. http://dx.doi.org/10.21474/ijar01/17812.
Pełny tekst źródłaShyam, Sharvari, and Bhavya Darshini Mahanthegowda. "A cost variation analysis of various brands of oral anti-diabetic drugs currently available in Indian pharmaceutical market." International Journal of Basic & Clinical Pharmacology 9, no. 8 (2020): 1253. http://dx.doi.org/10.18203/2319-2003.ijbcp20203144.
Pełny tekst źródłaKarki, Naresh, Kamal Kandel, Kyushu Shah, Pravin Prasad, and Jeevan Khanal. "Combination Therapy in Diabetes Mellitus Patients Attending Outpatient Department in a Tertiary Care Centre: A Descriptive Cross-sectional Study." Journal of Nepal Medical Association 60, no. 256 (2022): 1016–20. http://dx.doi.org/10.31729/jnma.7642.
Pełny tekst źródłaVerma, Suryakant, Milind Sharad Pande, Ravinder Kumar Mehra, et al. "Anti-diabetic Potential of Traditional Herbal Drugs in Polyherbal Formulation–A Review." Journal of Pharmaceutical Technology, Research and Management 12, no. 1 (2024): 33–51. https://doi.org/10.15415/jprtm.2024.121003.
Pełny tekst źródłaVerma, Suryakant, Milind Sharad Pande, Ravinder Kumar Mehra, et al. "Anti-diabetic Potential of Traditional Herbal Drugs in Polyherbal Formulation–A Review." Journal of Pharmaceutical Technology, Research and Management 12, no. 1 (2024): 33–51. https://doi.org/10.15415/jptrm.2024.121003.
Pełny tekst źródłaWu, Ping, Zhenyu Liu, Xiaohong Jiang, and Hao Fang. "An Overview of Prospective Drugs for Type 1 and Type 2 Diabetes." Current Drug Targets 21, no. 5 (2020): 445–57. http://dx.doi.org/10.2174/1389450120666191031104653.
Pełny tekst źródłaHong, Jun Hwa. "Extent of Role: Anti-Diabetic Medications." Journal of Korean Diabetes 23, no. 3 (2022): 153–56. http://dx.doi.org/10.4093/jkd.2022.23.3.153.
Pełny tekst źródłaHemamalini, Saravanan K. L. Senthil Kumar. "Formulation And Evaluation Of Medicated Chewing Gum Containing Metformin And Glimepiride." International Journal of Pharmaceutical Sciences 2, no. 4 (2024): 503–20. https://doi.org/10.5281/zenodo.10943964.
Pełny tekst źródłaMoumita, Hazra. "A Clinical Pharmacological Comparative Quantification Analytical Research Study Among Systematic Reviews and MetaAnalyses on Bronchodilators and Anti-Diabetic Drugs." International Journal of Toxicological and Pharmacological Research 12, no. 6 (2022): 50–57. https://doi.org/10.5281/zenodo.11656503.
Pełny tekst źródłaK., Lohit, Lakshmish Devang Halepalya Somashekar, Naveen Kumar, and Vidya K. R. "Anti-diabetic drugs prescription pattern by postgraduate students among type 2 diabetes patients attending a tertiary care hospital." International Journal of Basic & Clinical Pharmacology 8, no. 11 (2019): 2454. http://dx.doi.org/10.18203/2319-2003.ijbcp20194783.
Pełny tekst źródłaShadab, Usmani Humaira, Dr Mohd Muazzam Khan, ,. Dr Usama ahmad, et al. "Analysis of Prescribing Patterns and Adverse Drugs Reactions in Diabetic Patients at Tertiary Care Hospital, Lucknow." Indian Journal of Health Care, Medical & Pharmacy Practice 4, no. 1 (2023): 94–102. http://dx.doi.org/10.59551/ijhmp/2023.4.1.1010.
Pełny tekst źródłaShadab, Usmani Humaira, Dr Mohd Muazzam Khan, Dr Usama Ahmad, et al. "Analysis of Prescribing Patterns and Adverse Drugs Reactions in Diabetic Patients at Tertiary Care Hospital, Lucknow." Indian Journal of Health Care, Medical & Pharmacy Practice 4, no. 1 (2023): 94–102. http://dx.doi.org/10.59551/ijhmp.25832069.2023.4.1.10.
Pełny tekst źródłaShadab, Usmani Humaira, Dr Mohd Muazzam Khan, Dr Usama Ahmad, et al. "Analysis of Prescribing Patterns and Adverse Drugs Reactions in Diabetic Patients at Tertiary Care Hospital, Lucknow." INDIAN JOURNAL OF HEALTH CARE, MEDICAL AND PHARMACY PRACTICE 4, no. 1 (2023): 94–102. http://dx.doi.org/10.59551/ijhmp/2023.4.10.
Pełny tekst źródłaSingh, Dharmvir, Neetesh Kumar Jain, Apoorva Tiwari, and Neelam Khan. "Development and Validation of Simultaneous Equation Method for Estimation of Sitagliptin and Saxagliptin in Combined Pharmaceutical Dosage Form by Using UV Spectrophotometric Method." International Journal of Medical Sciences and Pharma Research 8, no. 2 (2022): 83–90. https://doi.org/10.22270/ijmspr.v8i2.43.
Pełny tekst źródłaTella, Toluwani, Carolina Pohl, and Kovalchuk Igor. "A review on diabetes mellitus: complications, synthetic anti-diabetic agents and herbal treatment." F1000Research 13 (February 19, 2024): 124. http://dx.doi.org/10.12688/f1000research.141015.1.
Pełny tekst źródłaAdeghate, Ernest. "Medicinal Chemistry of Novel Anti-Diabetic Drugs." Open Medicinal Chemistry Journal 5, Suppl 2 (2011): 68–69. http://dx.doi.org/10.2174/1874104501105010068.
Pełny tekst źródłaOyama, Jun-ichi, and Koichi Node. "Vascular failure and recent anti-diabetic drugs." Vascular Failure 1, no. 1 (2017): 2–8. http://dx.doi.org/10.30548/vascfail.1.1_2.
Pełny tekst źródłaTerauchi, Yasuo. "2. How to Select Anti-diabetic Drugs." Nihon Naika Gakkai Zasshi 110, no. 3 (2021): 556–61. http://dx.doi.org/10.2169/naika.110.556.
Pełny tekst źródłaDowarah, Jayanta, and Ved Prakash Singh. "Anti-diabetic drugs recent approaches and advancements." Bioorganic & Medicinal Chemistry 28, no. 5 (2020): 115263. http://dx.doi.org/10.1016/j.bmc.2019.115263.
Pełny tekst źródłaLi, Zhu, Jia Jia, Han Hao, et al. "Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity." Frontiers in Bioscience-Landmark 28, no. 5 (2023): 97. http://dx.doi.org/10.31083/j.fbl2805097.
Pełny tekst źródłaHulugappa, Lakshmi, Chethana Ramegowda, and Anwith Huluvadi Shivalingaiah. "Factors Influencing Oral Anti-diabetic Medication Adherence among Type 2 Diabetes Mellitus in Urban Health Training Centre, Bengaluru." National Journal of Community Medicine 13, no. 06 (2022): 386–90. http://dx.doi.org/10.55489/njcm.13062022405.
Pełny tekst źródłaParmar, Mrugank, and Shital Panchal. "REPURPOSING DIABETES DRUGS FOR NEURODEGENERATIVE DISEASES: ANTI-DIABETIC DRUG REPOSITION." International Research Journal Of Pharmacy 9, no. 12 (2019): 81–87. http://dx.doi.org/10.7897/2230-8407.0912297.
Pełny tekst źródłaWu, Victor Chien-Chia, Yan-Rong Li, and Chao-Yung Wang. "Impact of Sodium–Glucose Co-Transporter 2 Inhibitors on Cardiac Protection." International Journal of Molecular Sciences 22, no. 13 (2021): 7170. http://dx.doi.org/10.3390/ijms22137170.
Pełny tekst źródłaChang, Wenguang, Li Chen, and Grant M. Hatch. "Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies." Biochemistry and Cell Biology 93, no. 5 (2015): 479–86. http://dx.doi.org/10.1139/bcb-2014-0107.
Pełny tekst źródłaPelin, Ana Maria, Cristian Catalin Gavat, Gabriela Balan, and Costinela Valerica Georgescu. "Pharmacological Principles Used in Patient Monitoring with Type 2 Diabetes." Revista de Chimie 68, no. 2 (2017): 378–83. http://dx.doi.org/10.37358/rc.17.2.5457.
Pełny tekst źródłaRauniyar, G. P., R. Sinha, K. Chapagain, R. Maskey, and D. R. Pandey. "Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study." Kathmandu University Medical Journal 19, no. 2 (2021): 243–47. http://dx.doi.org/10.3126/kumj.v19i2.49655.
Pełny tekst źródłaKim, Kyung-Soo, and Byung-Wan Lee. "Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease." Clinical and Molecular Hepatology 26, no. 4 (2020): 430–43. http://dx.doi.org/10.3350/cmh.2020.0137.
Pełny tekst źródłaSUVASHINI CHELLADURAI, MONIKA ARUMUGAM, ARUNKUMAR JEYARAJ, et al. "Study of cost variation analysis for oral anti-diabetic drugs dispensed in pharmacy." World Journal of Biology Pharmacy and Health Sciences 21, no. 2 (2025): 150–54. https://doi.org/10.30574/wjbphs.2025.21.2.0111.
Pełny tekst źródła